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Peroxiredoxins (Prxs) are ubiquitous antioxidants that protect cells
against oxidative stress. We show that the yeast Tsa1/Tsa2 Prxs
colocalize to ribosomes and function to protect the Sup35 trans-
lation termination factor against oxidative stress–induced forma-
tion of its heritable [PSI+] prion conformation. In a tsa1 tsa2 [psi-]
[PIN+] strain, the frequency of [PSI+] de novo formation is signifi-
cantly elevated. The Tsa1/Tsa2 Prxs, like other 2-Cys Prxs, have
dual activities as peroxidases and chaperones, and we show that
the peroxidase activity is required to suppress spontaneous de
novo [PSI+] prion formation. Molecular oxygen is required for
[PSI+] prion formation as growth under anaerobic conditions pre-
vents prion formation in the tsa1 tsa2 mutant. Conversely, oxida-
tive stress conditions induced by exposure to hydrogen peroxide
elevates the rate of de novo [PSI+] prion formation leading to
increased suppression of all three termination codons in the tsa1
tsa2 mutant. Altered translational fidelity in [PSI+] strains may
provide a mechanism that promotes genetic variation and pheno-
typic diversity (True HL, Lindquist SL (2000) Nature 407:477–483). In
agreement, we find that prion formation provides yeast cells with
an adaptive advantage under oxidative stress conditions, as elim-
ination of the [PSI+] prion from tsa1 tsa2 mutants renders the
resulting [psi-] [pin-] cells hypersensitive to hydrogen peroxide.
These data support a model in which Prxs function to protect
the ribosomal machinery against oxidative damage, but when
these systems become overwhelmed, [PSI+] prion formation pro-
vides a mechanism for uncovering genetic traits that aid survival
during oxidative stress conditions.
Peroxiredoxins (Prxs) are ubiquitous, thiol-specific proteinsthat have multiple functions in stress protection. Typical 2-
Cys Prxs are active as a dimer and contain two redox active Cys
residues that are directly involved in enzyme activity (1). During
catalysis, the peroxidatic cysteine is oxidized to a sulphenic acid,
which then condenses with a resolving cysteine (from the other
subunit of the dimer) to form a disulphide. This disulphide is
reduced by thioredoxin in a redox cycle that accepts electrons
from NADPH. In addition to their peroxidase function, Prxs
have proposed roles in diverse cellular processes including dif-
ferentiation, proliferation, modulation of intracellular signaling,
apoptosis, and gene expression, and have become increasingly
implicated in many disease processes (2).
Tsa1 is the major 2-Cys Prx in yeast and has best been char-
acterized as an antioxidant in the detoxification of hydroperoxides
(3, 4). More recently, it has been shown to be particularly required
as an antioxidant that protects against oxidative damage arising as
a result of endogenous reactive oxygen species (ROS) generated
during normal aerobic metabolism (5). Mutants lacking TSA1
accumulate significant levels of DNA damage, causing genome
instability and cell death during normal aerobic growth con-
ditions. Tsa1 can also act as a molecular chaperone that promotes
resistance to heat and reductive stresses (6, 7). Loss of TSA1
results in aggregation of ribosomal proteins, suggesting that Tsa1
functions to protect the translation apparatus against oxidative
damage (7).
Tsa1 functions as a peroxidase on ribosomes, as mutation of its
peroxidatic cysteine residue, which inactivates its peroxidase but
not its chaperone activity, results in sensitivity to translation in-
hibitors such as cycloheximide and hygromycin. Approximately 5%
of cellular Tsa1 is associated with ribosomes during normal growth
conditions (8). However, the function of this pool is unclear, as loss
of TSA1 does not affect the translation process during normal
aerobic growth conditions.
The Tsa2 Prx is highly homologous to Tsa1 (86% amino acid
identity) and possesses similar peroxidase and chaperone activ-
ities, although it is normally expressed at significantly lower
levels compared with Tsa1 (4, 6). We show here that the majority
of cellular Tsa2 localizes to ribosomes. This prompted us to
examine whether the simultaneous deletion of TSA1 and TSA2
causes any defect in translation, and we find that cultures of tsa1
tsa2 mutants display increased suppression of all three trans-
lation termination codons. Elevated readthrough of termination
codons is a well known phenotype of the yeast [PSI+] prion, a
conformationally altered form of the Sup35 translation termi-
nation factor (9). Sup35 is an essential protein, which, together
with its interacting partner Sup45, facilitates the termination of
translation and polypeptide chain release (10). Sup35 forms
[PSI+] prion aggregates that sequester it away from its normal
function in translation termination, resulting in suppression of all
three stop codons. [PSI+] prion formation is known to increase
in response to environmental stress conditions, including H2O2
stress (11). We therefore examined [PSI+] prion formation in the
tsa1 tsa2 mutant and we show that this mutant shows a sig-
nificantly elevated frequency of de novo formation of [PSI+] that
would account for the nonsense suppression observed in a cul-
ture of a tsa1 tsa2 strain. As [PSI+] prion formation can provide
a mechanism for uncovering hidden genetic variation that pro-
motes phenotypic diversity (12, 13), the ability to form the [PSI+]
prion in the tsa1 tsa2 mutant may provide an adaptive advantage,
as tsa1 tsa2 [pin−] mutants, which are unable to form [PSI+]
prions, are hypersensitive to H2O2 stress.
Results
The Tsa1 and Tsa2 Peroxiredoxins Localize with Ribosomes. Approx-
imately 5% of Tsa1 is associated with ribosomes (8).We therefore
examined Tsa2 to determine whether it is similarly ribosome-
associated. Cell extracts were treated with cycloheximide to
inhibit ribosomal translocation, and ribosomal fractions sepa-
rated from soluble components by centrifugation through sucrose
cushions. Known ribosomal markers including elongation factor
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Tef1 (EF-1A), termination factor Sup35 (eRF3), and ribosomal
protein Rps3 were detected in ribosomal fractions as expected
(Fig. 1A). Tsa1 was present in both ribosomal and soluble frac-
tions, whereas another Prx, Ahp1, was only detected in the soluble
fraction as previously described (8). Interestingly, Tsa2 was
exclusively localized in ribosomal fractions and was not detected
in the soluble fraction.
Tsa1 and Tsa2 are thought to have overlapping functions in
protecting cells against oxidative stress (4), and their colocali-
zation on the ribosome suggests that they play a common role in
protecting the protein synthetic machinery against oxidative
stress conditions. Although loss of TSA1 alone does not affect
translational fidelity as measured by the readthrough of a UAA
stop codon (8), stop codon readthrough was observed in a tsa1
tsa2 mutant of W303 as quantified using a reporter plasmid that
carries the lacZ gene with a premature UAA, UAG, or UGA
stop codon (14). Readthrough of all three stop codons was ele-
vated in this tsa1 tsa2mutant compared with the WTW303 strain
ranging between threefold (UAA), fivefold (UAG), and 20-fold
(UGA) (Fig. 1B). A similar increase in UAG codon readthrough
was observed in the tsa1 single mutant, which may indicate that
Tsa1 has an additional function on ribosomes distinct from that
of Tsa2.
Tsa1 and Tsa2 Peroxiredoxins Protect Against Sup35 Prion Formation.
Given that elevated readthrough of termination codons is a
well known phenotype of the yeast [PSI+] prion, we examined
whether the termination readthrough detected in the tsa1 tsa2
mutant culture correlated with an increase in [PSI+] prion for-
mation in cultures of this mutant. The subcellular distribution of
Sup35 was examined in exponential phase cultures of WT and Prx
mutants, and this showed that Sup35 was in the soluble fraction in
WT and tsa1 and tsa2 single mutants, whereas in the tsa1 tsa2
double mutant, a significant proportion was present in an SDS-
insoluble high molecular weight form (Fig. 2A). The de novo
formation of Sup35 aggregates was also observed in tsa1 tsa2 cells
using a fusion between the aminoterminal domain of Sup35 and
GFP, under the control of the CUP1 promoter (15). In WT cells,
strong cytoplasmic fluorescence comparable with a [psi−] control
strain was seen (Fig. 2B), whereas many different-sized aggregates of Sup35 were detected in the majority (>95% of 200 cells
examined) of tsa1 tsa2 mutants examined in two repeat experi-
ments, similar to those seen in a [PSI+] strain (15).
One genetic criterion for a yeast prion is reversible curability
(9). Guanidine hydrochloride (GdnHCl) blocks the propagation
of yeast prions by inhibiting Hsp104, a molecular chaperone that
is absolutely required for yeast prion propagation (16, 17). [PSI+]
prions form SDS-resistant high molecular weight aggregates that
can be detected using semidenaturing detergent agarose gel
electrophoresis (SDD-AGE) (18). Such Sup35 aggregates were
also observed in a tsa1 tsa2 mutant of W303 and in the control
[PSI+] strain 74D-694 (Fig. 2C). Growth of the tsa1 tsa2mutant in
the presence of GdnHCl shifted Sup35 back to its monomeric
size, confirming the requirement for Hsp104 to propagate [PSI+]
prion formation in this strain.
The reversible curability of the [PSI+] prion in the W303 tsa1
tsa2 mutant was confirmed using a genetic assay in a different
strain background. TSA1 and TSA2 were deleted in a [psi–]
derivative of the 74D-694. This strain contains an ade1-14, a
nonsense (UGA) mutant allele that confers adenine autotrophy,
and 74D-694 [psi–] cells accumulate a red pigment. Suppression of
the ade1-14 nonsense mutation by [PSI+] gives rise to white/pink
Ade+ colonies. The tsa1 tsa2 mutant of 74D-694 gave rise to
white/pink Ade+ colonies at a very high frequency (Fig. 2D) and
the Ade+ phenotype was eliminated by growth in the presence of
3 mM GdnHCl, suggesting that this was a result of the de novo
formation of [PSI+] in these cells (Fig. 2E). GdnHCl also caused
loss of the diagnostic SDS-resistant Sup35 polymers in this
Fig. 1. Tsa1 and Tsa2 colocalize with ribosomes and prevent suppression of
translation termination. (A) Ribosomal fractions (R) were separated from
soluble components (S) by centrifugation through sucrose cushions. Proteins
were separated by SDS/PAGE and Tef1, Rps3, Sup35, Tsa1, Ahp1, and Tsa2
detected by immunoblot analysis. (B) The levels of termination codon
readthrough were measured using a β-gal reporter system in cultures of WT
(W303), tsa1, tsa2, and tsa1 tsa2 mutants grown to exponential phase in
minimal SD media. Readthrough was quantified using plasmids that carry
the lacZ gene that bears a premature termination codon. Values shown are
means ± SE mean from at least three independent determinations. Read-
through is expressed as a proportion of control β-gal levels, measured in
transformants carrying the control plasmid that carries the WT lacZ gene.
Fig. 2. The Tsa1 and Tsa2 Prxs protect against Sup35 prion formation. (A)
Subcellular distribution of Sup35 in WT (W303), tsa1, tsa2, and tsa1 tsa2
mutant cells grown to exponential phase in minimal SD media. Subcellular
fractionation analysis of Sup35 was performed as described in Experimental
Procedures using an anti-Sup35 polyclonal antibody. (T, total crude extract;
S, soluble fraction; P, pellet fraction.) Representative gels are shown from at
least three independent repeats. (B) Fluorescence micrographs of the W303
WT and tsa1 tsa2mutant and [PSI+] and [psi−] derivatives of 74D-694 carrying
plasmid p6442 (CUP1-SUP35NM-GFP). (C) Detection of SDS-resistant Sup35
aggregates by SDD-AGE in cell lysates from WT (W303) tsa1, tsa2, and tsa1
tsa2 mutants, and [psi−] [pin−], [psi−] [PIN+], and [PSI+] [PIN+] derivatives of
74D-694. The tsa1 tsa2 mutant was also grown in the presence of 3 mM
GdnHCl. (D) WT (74D-694) and tsa1 tsa2 mutants were streaked on YEPD
media and colony color visualized after 3 d growth. (E) [PSI+] prion for-
mation was assayed in the WT (74D-694) and mutant strains by pink/white
colony formation and growth on minimal media in the absence of adenine.






putative [PSI+] tsa1 tsa2 strain (Fig. S1), and expression of the
ATPase-deficient allele of Hsp104 (hsp104::K218T, K620T) also
generated red Ade− colonies (Fig. 2E), as has been previously
described for [PSI+] cells (19).
Using the 74D-694 tsa1 tsa2 mutant we differentiated between
[PSI+] prion formation and any spontaneous nonsense suppressor
mutations that might have arisen as a result of the previously
described mutator phenotype displayed by tsa1 tsa2 mutants (5).
Colony-purified red Ade+ 74D-694 tsa1 tsa2 mutants were
streaked for single colonies on Yeast Extract Peptone Dextrose
(YEPD) media (Fig. 2D) and 120 of the independently arising
white/pink colonies were checked for curability of the Ade+
phenotype by growth in the presence of 3 mM GdnHCl. Eighty-
five percent of themutants examined were curable, indicating that
these were [PSI+] strains rather than nuclear-encoded nonsense
suppressors. GdnHCl treatment also cures the [PIN+] prion,
which is absolutely required for de novo formation of [PSI+] (20),
and so we also tested 108 of the cured 74D-694 tsa1 tsa2 mutants
for their ability to form [PSI+] prions. In all cases, few white/pink
colonies were detected and all 13 such independent Ade+
revertants tested were noncurable on 3 mM GdnHCl, i.e., were
not [PSI+]. These data also show that the absence of Tsa1 and
Tsa2 does not override the need for the [PIN+] prion for de novo
formation of [PSI+].
As tsa1 tsa2 mutants were sterile, we were unable to carry out
genetic crosses or cytoduction experiments to confirm the pres-
ence of a transmissible infectious entity in the spontaneous
[PSI+] tsa1 tsa2 mutants. We therefore resorted to the “protein
transformation” method recently described by Tanaka et al. (21)
to demonstrate that one of the spontaneous tsa1 tsa2 [PSI+]
strains derived from W303 contained such infectious entities that
can be transmitted to a [psi−] strain. Of 49 transformants derived
using this extract, 13 were [PSI+], and 11 of 54 transformants
obtained with an extract of the 74D-694 [PSI+] strain were
[PSI+]. No [PSI+] cells were obtained among 74 transformants
using an extract from a [psi−] 74D-694 derivative.
Prion Formation in the tsa1 tsa2 Mutant Requires Oxygen. As Tsa1
can function as both a peroxidase in the detoxification of hydro-
peroxides, and as a molecular chaperone that protects against
protein misfolding, we determined which of these activities are
important for preventing Sup35 aggregation and de novo for-
mation of the [PSI+] prion. Introduction of a WT plasmid copy of
TSA1 into the Ade− W303 tsa1 tsa2 mutant resulted in Sup35
being largely redistributed into the soluble fraction (Fig. 3A).
Mutants lacking the peroxidatic (Cys47) or the resolving (Cys170)
cysteine residue cannot function as peroxidases, but maintain
chaperone activity (6). Sup35 aggregation was still detected cells
expressing various Tsa1 cysteine mutants (Tsa1C47S, Tsa1C170S,
Tsa1C47S/C170S), indicating that the peroxidase activity, rather
than the chaperone activity, protects against de novo [PSI+] prion
formation (Fig. 3A).
To determine whether oxygen is required for the spontaneous
de novo formation and propagation of the [PSI+] prion in a tsa1
tsa2 mutant, we exploited a can1-100 nonsense (UAA) allele of
the arginine permease gene CAN1, which is present in W303
and confers resistance to the toxic arginine analogue canavanine
(Fig. 3B). Suppression of the UAA codon leads to a canavanine-
sensitive phenotype, and this was observed with cultured cells
of W303 tsa1 tsa2 mutant. That this canavanine sensitivity was
dependent on [PSI+] prion formation was confirmed by com-
paring with a parallel culture grown in the presence of 3 mM
GdnHCl (Fig. 3B). Interestingly, the same tsa1 tsa2 strain grown
in low oxygen conditions was far less resistant to canavanine,
suggesting that [PSI+] prion formation in this strain might be de-
pendent on the presence of oxygen. We confirmed this hypoth-
esis by examining the subcellular distribution of Sup35 in the
W303 tsa1 tsa2 mutant grown under anaerobic conditions, in the
absence of atmospheric oxygen. Subculturing the cells five times
under anaerobic growth conditions resulted in Sup35 shifting
from an SDS-insoluble high molecular weight form into a soluble
form (Fig. 3C). This behavior was specific to the tsa1 tsa2mutant,
as the propagation of the [PSI+] prion in a control [PSI+] TSA1
TSA2 strain was unaffected by anaerobic growth. These results
suggest that the accumulation of ROS in the tsa1 tsa2 mutant
specifically triggers [PSI+] prion formation.
Curable Prion Formation Is Induced by Oxidative Stress. Tsa1 and
Tsa2 have best been characterized as antioxidants that protect
cells against oxidative stress induced by H2O2. Additionally, sev-
eral unrelated environmental stress conditions including H2O2
have been reported to increase the frequency of [PSI+] prion
formation de novo (11). We therefore examined whether [PSI+]
prion formation is elevated in a tsa1 tsa2mutant exposed to H2O2.
WT W303 and a tsa1 tsa2 mutant derivative were grown to
exponential phase and treated with sublethal levels (100 μM) of
H2O2 for 20 h. The WT strain underwent approximately five
doublings during this treatment, whereas the tsa1 tsa2mutant was
more sensitive and divided only approximately three times. Sup35
remained largely soluble in the WT strain following this H2O2
treatment, although a small amount was detectable in the high
molecular weight fraction (Fig. 4A). Growth of the tsa1 tsa2
mutant in the presence of H2O2 resulted in a large increase in the
Fig. 3. Prion formation in the tsa1 tsa2 mutant requires oxygen. (A)
Subcellular distribution of Sup35 in the tsa1 tsa2 mutant cells containing
WT Tsa1 (pTSA1) or cysteine mutants of Tsa1 (pTSA1C47S, pTSA1C170S,
pTSA1C47S, C170S) as the sole source of TSA1. (B) [PSI+] prion formation
assayed in cured [psi−] [pin−] and noncured WT (W303) [psi−] [PIN+] and
tsa1 tsa2 [PSI+] [PIN+] mutant strains assayed by growth on canavanine. The
can1-100 allele in W303 contains a UAA nonsense mutation and trans-
lation termination at this stop codon confers resistance to canavanine.
Cells were grown to stationary phase, diluted to A600s of 1.0, 0.1, and 0.01,
and spotted onto minimal SD plates containing 80 μg/mL canavanine
under aerobic or anaerobic conditions. (C ) Subcellular distribution of
Sup35 in the WT W303 [psi−] [PIN+], tsa1 tsa2 [PSI+] [PIN+] mutant, and
[PSI+] [PIN+] derivatives of 74D-694. Cells were grown under aerobic or
anaerobic conditions in minimal SD media as described in the text.
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proportion of Sup35 in the high molecular weight fraction. To
confirm that H2O2 stress promotes [PSI
+] prion formation, we
repeated the experiment but this time in GdnHCl-cured [pin−]
derivatives. Now the Sup35 was largely absent from high molec-
ular weight fractions of the tsa1 tsa2 [pin−] strains. These data
indicate that oxidative stress promotes de novo [PSI+] prion
formation rather than any suppressor mutations that might affect
Sup35 aggregation (Fig. 4A).
Termination readthrough was assayed to confirm that the pre-
dicted [PSI+]-associated nonsense suppression correlated with
the presence of Sup35 in soluble versus insoluble fractions.
Readthrough of stop codons was unaffected by oxidative stress in
the WT W303 strain (Fig. 4B). In contrast, nonsense suppression
was elevated by approximately two to three fold for all three stop
codons in the W303 tsa1 tsa2 mutant. Whereas readthrough of
the UAA and UAG stop codons was restored to WT levels in
the GdnHCl cured tsa1 tsa2 [pin−] mutant, readthrough of the
UGA stop codon remained elevated compared with the WT
strain. That there was no further increase in response to H2O2
in this mutant suggests that there may also be a [PSI+] prion–
independent translation termination defect that specifically af-
fects UGA nonsense suppression in a tsa1 tsa2 mutant.
Taken together, our data indicate that the Tsa1 and Tsa2 Prxs
protect against oxidative stress-induced [PSI+] prion formation.
One possible consequence of [PSI+] prion formation is that it
can alter gene expression patterns through altered stop codon
recognition. We therefore examined whether the ability to form
the [PSI+] prion influences the sensitivity of the tsa1 tsa2 mutant
to oxidative stress conditions. The Tsa1 and Tsa2 Prxs are active
as antioxidants and growth of the tsa1 tsa2 mutant in the pres-
ence of 100 μMH2O2 for 20 h lowered viability by approximately
50% compared with the WT strain (Fig. 4C). Strikingly, the
GdnHCl cured tsa1 tsa2 [pin−] mutant cells, which are unable to
form [PSI+] de novo, was hypersensitive to H2O2 and lost greater
than 99% viability following peroxide treatment.
Discussion
The [PSI+] prion is an infectious, self-perpetuating form of
Sup35, an essential translation termination factor. When Sup35
shifts to its transmissible prion conformation, it becomes un-
available for translation termination, resulting in readthrough of
nonsense codons (9). The molecular basis of how yeast prions
such as [PSI+] nucleate de novo into the infectious amyloid-like
structures that underlie the [psi−]-to-[PSI+] transition is poorly
understood at present.
Here, we show that the Tsa1/Tsa2 Prxs suppress oxidative
stress–induced de novo formation of the [PSI+] prion. This raises
the question how oxidation influences the formation of the
Sup35 prion conformation. Hsp104 and a number of molecular
chaperones are required for the continued propagation of [PSI+]
and other yeast prions (22). Hsp104 expression is induced in
response to oxidative stress conditions, but this cannot account
for the high frequency of de novo [PSI+] prion formation in the
tsa1 tsa2 mutant as elevated levels of Hsp104 promote [PSI+]
loss rather than facilitating its de novo formation (19). However,
it is possible that oxidant-induced changes in expression of the
protein homeostasis network may account for [PSI+] prion for-
mation. Alternatively, direct oxidation of Sup35 may generate
structural conformations that favor a shift to the transmissible
amyloid-like form. This would be analogous to various environ-
mental factors which have been proposed to trigger misfolding of
the mammalian prion protein (PrPC) into the aggregated scrapie
form (PrPSc) (23).
All amino acids in proteins are potential targets for oxidation,
but cysteine and methionine residues are particularly susceptible
to oxidation by ROS. Sup35 can be divided into three functional
regions demarked by methionine residues: an N-terminal region
(residues 1–123) that is essential for prion formation, a highly
charged middle (M) region (residues 124–253), and a C-terminal
region (residues 254–685) that is required for translation ter-
mination activity (24). The N and M regions contain no cysteine
residues, but the M region is flanked by methionine residues.
Interestingly, oxidation of methionine residues in purified PrPC
may cause the α-to-β structural conversion that underlies the
sporadic formation of PrPSc (25). Direct oxidation of Sup35
methionine residue (or other residues) may therefore facilitate
the conformational conversion to the prion form.
That Tsa1 and Tsa2 are required to maintain genome stability
during growth on glucose-based media suggests that sufficient
endogenous ROS are generated to damage cellular macromol-
ecules during normal aerobic growth (5). Loss of TSA1 has been
correlated with protein damage and aggregation during similar
growth conditions (6, 7), and we show here that [PSI+] prion
formation increases significantly in the tsa1 tsa2 mutant during
normal aerobic growth conditions. We confirmed that this is an
oxygen-dependent mechanism, as growth in the absence of mol-
ecular oxygen significantly reduces the de novo appearance of the
[PSI+] prion in a tsa1 tsa2 mutant. Oxidative stress conditions
induced by exposure to H2O2 were found to further elevate the
frequency of de novo formation of the [PSI+] prion, suggesting
that the extent of Sup35 aggregation correlates with the degree of
oxidative stress suffered by the cell.
The loss of the nonsense suppression phenotype from the tsa1
tsa2 [PSI+] strains when Hsp104 activity is inhibited by GdnHCl is
consistent with a self-replicating prion state. For example, cells
expressing an aggregating but noninheritable form of Sup35p (e.g.,
those formed by an Aβ–Sup35p fusion) do not show loss of the
nonsense suppression phenotype in the presence of GdnHCl (26).
The demonstration that a transmissible prion entity is present in a
tsa1 tsa2 [PSI+] coupled with the presence of SDS-resistant
Fig. 4. [PSI+] prion formation is induced by oxidative stress. (A) Subcellular
distribution of Sup35 in cured and noncured WT (W303) and tsa1 tsa2
mutants grown in minimal SD media and treated with 100 μM H2O2 for 20 h.
The levels of termination codon readthrough (B) and cell viability (C) were
measured for the same strains and growth conditions as described in A.
Percentage survival is expressed relative to untreated cultures.






aggregates of Sup35 in the same strain confirms that transmissible
forms of the [PSI+] prion are formed in the tsa1 tsa2 mutant.
Tsa1 and Tsa2 are the only antioxidants that have so far been
shown to localize on ribosomes. Despite the finding that Tsa1/
Tsa2 apparently function to protect Sup35 on ribosomes, it is not
clear why the protein synthetic machinery should be a particular
target of oxidative damage. It may simply reflect the relative
abundance of ribosomes and ribosome-associated proteins. There
is also increasing evidence that the translational apparatus is a
target of oxidative damage and such damage has been implicated
in the pathogenesis of a number of major neurodegenerative
disorders, including Alzheimer disease and other protein mis-
folding disorders (27, 28).
Tsa1 is the major yeast Prx (4), and we show here that loss of
both TSA1 and TSA2 results in a 50% decrease in cell viability
following exposure to a normally nonlethal treatment with H2O2.
H2O2 treatment also leads to a significant elevation in the fre-
quency of de novo [PSI+] prion formation (11), which in turn
increases the readthrough of all translation termination codons.
The elimination of [PSI+] by GdnHCl from the tsa1 tsa2 mutant
caused the mutant to become hypersensitive to H2O2, reducing
cell viability to less than 0.1% of the WT strain following the
same oxidant treatment. This suggests that the ability to form
the [PSI+] prion provides a selective advantage to the tsa1 tsa2
mutant during exposure to oxidative stress conditions. However,
it remains possible that [PIN+] or even other GdnHCl-curable
prions could be responsible for relieving the peroxide sensitivity
of the tsa1 tsa2 mutant without the appearance of [PSI+].
Resistance to several environmental stress conditions does cor-
relate with the [PSI+] versus [psi−] status of cells (12, 13).
Additionally, [PSI+]-induced effects on frame shifting increase
the levels of antizyme, a negative regulator of polyamine bio-
synthesis. The resulting alterations in polyamine synthesis can
account for many of the reported changes in sensitivity to envi-
ronmental insults which have been correlated with the [PSI+]
prion status of cells (29). The shift to the [PSI+] prion state may
therefore allow cells to reprogram gene expression such that new
genetic traits become uncovered that aid survival during the
altered conditions (11). Our findings support the hypothesis that
prion-induced changes in gene expression provide a mechanism
to uncover normally hidden genetic traits, which in this case aid
survival under oxidative stress conditions. Tsa1 and Tsa2 nor-
mally act to prevent oxidant-induced [PSI+] prion formation, but
overwhelming this defense system provides an evolvable mech-
anism to survive the ensuing oxidative stress conditions.
Experimental Procedures
Yeast Strains, Plasmids, and Growth Conditions. The WT strain W303 (MATa
ura3-52 leu2-3 leu2-112 trp1-1 ade2-1 his3-11 can1-100, [PIN+]) and its iso-
genic derivative deleted for TSA1 (tsa1::LEU2) have been described pre-
viously (7). Strains deleted for TSA2 (tsa2::KANMX ) were constructed using
standard yeast methodology. [PSI+], [psi−], and hsp104::K218T, K620T
derivatives of 74D-694 (MATa ade1-14 trp1-289 his3-200 ura3-52 leu2-3,112,
[PIN+]) have been described previously (17). The centromeric plasmids pFL-
TSA1 and pFL-TSA1C47S have been described previously (30) and pFL-
TSA1C170S and pFL-TSA1C47S,C170S plasmids were constructed as part of this
study using the QuickChange II site-directed mutagenesis kit (Stratagene).
Strains were grown in rich YEPD medium (2% wt/vol glucose, 2% wt/vol
Bacto-Peptone, 1% wt/vol yeast extract) or minimal SD medium (0.17% wt/
vol yeast nitrogen base without amino acids, 5% wt/vol ammonium sulfate,
2% wt/vol glucose) supplemented with appropriate amino acids and bases at
30 °C and 180 rpm. Strains were cured by growth on YEPD agar plates
containing 3 mM GdnHCl. For anaerobic plate growth, plates were main-
tained in an anaerobic jar (Oxoid) containing a gas generating kit (anaerobic
system BR38; Oxoid). Anaerobic culture conditions were established using SD
media, which was degassed with nitrogen gas as previously described (31).
Translation Termination Assays. The levels of termination codon readthrough
were measured using a β-gal reporter system (10). For genetic assays of
termination codon readthrough, strains were grown to stationary phase,
serially diluted (OD600 = 1.0, 0.1, 0.01, 0.001) and spotted onto appropriate
plates. Readthrough of the UAA stop codon in the can1-100 allele was
determined by examining growth on SD media containing various concen-
trations of canavanine. Readthrough of the UGA stop codon in the ade1-114
allele was determined by examining growth on SD media lacking adenine
and red/white colony color visualized on 1/4 YEPD media.
Protein Analysis. Ribosomal fractions were separated from soluble compo-
nents by centrifugation through sucrose cushions (8). The analysis of Sup35
aggregates by subcellular fractionation was performed as described pre-
viously (32). Analysis of Sup35 aggregates by SDD-AGE was performed as
described elsewhere (33). De novo [PSI+] prion formation was visualized using
the CUP1-SUP35NM-GFP plasmid (34). Cells were grown to early exponential
phase (A600 = 0.5) in SD minimal media, and 50 μM copper sulfate added for
5 h for induction of the CUP1 promoter.
Protein Transfection. Theprotocol described by Tanaka et al. (21)was followed
essentially as described. Crude extracts were prepared from yeast strains
using the protocol described by Kryndushkin et al. (33). Spheroplasts were
made from the strain 74D-694 [psi-] [PIN+] using Lyticase (Sigma-Aldrich) and
transformations carried out with plasmid p6442 (SUP35NM-GFP) selecting for
the URA3 marker carried by this plasmid.
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